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Ex vivo produced oral mucosa equivalent
preliminary report: a technical note
Gürkan Raşit BAYAR

Aim: The aim of this study was to produce of ex vivo oral mucosal equivalent. The continuous stratified layer of human
oral keratinocytes was grown on a cadaveric human dermal matrix in a defined culture medium without a feeder layer.
Materials and methods: Human oral keratinocytes from a keratinized oral mucosa biopsy specimen were enzymatically
dissociated and cultured in a serum-free defined culture medium, “EpiLife” (Cascade Biologics, Portland, OR, USA),
containing a low calcium concentration of 0.06 mM. Oral keratinocytes were expanded one passage. Once a sufficient
population of keratinocytes was reached, they were seeded onto the type IV collagen coated acellular nonimmunogenic
cadaveric human dermis (AlloDerm), at cell densities of 1.8 × 105. To form a continuous epithelial monolayer, and to
enhance keratinocyte differentiation, oral keratinocyte-AlloDerm composites were cultured while submerged in a high
calcium concentration of 1.2 mM medium for 4 days. After 4 days, AlloDerm-keratinocyte composites were raised to an
air-liquid interface to encourage stratification of the epithelial monolayer. After additional 7 days, they were taken for
histologic examination at 11 days postseeding of the keratinocytes on the AlloDerms.
Results: Histologically, on day 11, EVPOME’s development showed multilayered epithelium comprising basal, suprabasal,
and parakeratinized layers.
Conclusion: Histologically, an ex vivo produced oral mucosa equivalent (EVPOME) that consisted of a stratified
epidermis on a dermal matrix was successfully developed by the method used.
Key words: Oral, mucosa, substitute, ex vivo, production

Vücut dışında üretilmiş ağız mukozası eşdeğeri
ön çalışma raporu: Bir teknik not
Amaç: Bu çalışmanın amacı, vücut dışında insan ağız mukozası eşdeğeri üretmekti. İnsan ağız mukozası
keratinositlerinden oluşan ve devamlı, sıralı şekilde katmanlanmış olan canlı bir tabaka, kadavradan elde edilmiş olan
hücresiz insan deri matriksi üzerinde ve tanımlanmış bir doku kültürü solüsyonu ortamında, hayvan kaynaklı besleyici
herhangi bir materyal kullanılmadan üretilmeye çalışıldı.
Yöntem ve gereç: Keratinize ağız mukozası biyopsi örneğinden elde edilen insan ağız mukozası keratinositleri enzimatik
olarak ayrıştırıldı ve hayvan kaynaklı herhangi bir besleyici materyal içermeyen, 0,06 mM. oranında düşük kalsiyum
içeren, tanımlanmış bir kültür ortamında “EpiLife” (Cascade Biologics Portland, OR, USA), bir pasaj çoğaltıldı. Yeterli
keratinosit popülasyonuna ulaşıldıktan sonra, keratinositler tip IV kollajen emdirilmiş hücresiz, immünojenik olmayan
kadavradan elde edilmiş deri matriksi (AlloDerm) üzerine 1,8 × 105 hücre dansitesi ile ekildi. Devamlı tek tabakalı
epiteliyal bir katman elde etmek ve keratinosit farklılaşımını hızlandırmak amacıyla, ağız mukozası keratinositleri ve
AlloDerm’ den oluşan doku kompoziti, 1,2 mM yüksek kalsiyum konsantrasyonu içeren, tanımlanmış doku kültürü
solüsyonu içerisine batacak şekilde 4 gün kültüre edildi. AlloDerm-keratinosit doku kompoziti, epiteliyal tek tabakanın
katmanlaşmasını uyarmak maksadıyla, 4 gün sonra hava-sıvı etkileşimli ortama aktarıldı. Bu ortamda geçen 7 günden
sonra ise, toplam 11 gün sonra, doku kompoziti örnekleri histolojik inceleme için hazırlandı.
Bulgular: Histolojik olarak 11. günde, vücut dışında üretilmiş ağız mukozası eşdeğeri, bazal, suprabazal ve parakeratinize
tabakalardan oluşan çok katlı bir epitel gelişimi sergiledi.
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Sonuç: Histolojik olarak, kullanılan yöntemle, vücut ortamı dışında hücresiz bir dermal matriks üzerinde doğal olarak
katmanlanmış epidermis başarıyla üretilmiş oldu.
Anahtar sözcükler: Ağız, mukoza, eşdeğer, vücut dışı, üretim

Introduction
Burns, chronic ulcers, and most reconstructive
procedures in oral and maxillofacial surgery require
skin and oral mucosa substitutes for enhancing the
healing of wounds. Autogenous keratinized oral
mucosa and split thickness skin grafts are still being
used despite their disadvantages like requiring a
second surgical procedure, limiting to supply and
unsuitable texture of skin grafts for intraoral grafting.
However, the ability to produce ex vivo oral mucosa
equivalent from a punch biopsy, composed of an
epithelial and dermal component, within 1 to 2
months can assist oral and maxillofacial surgeons.
This will make available an unlimited supply of oral
tissue that will have similar characteristics to native
mucosa (1-3).
In designing a tissue-engineering human oral
mucosal equivalent, it should duplicate the tissue’s
anatomic structures and physiologic functions. In the
development of a mucosal equivalent 2 basic
components exist: a superficial portion or epidermis
that contains keratinocytes, and the deeper portion or
dermis (4).
In the past, Rheinwald and Green’s technique (5)
was used to fabricate cultured oral epithelial sheets.
Their protocol was using a feeder layer composed of
irradiated 3T3 mouse fibroblasts to grow
keratinocytes in vitro. Oral mucosal sheets cultured
with an irradiated feeder cell layer were undesirable
in elective surgery because of the undetermined risk
of introducing a high mouse DNA content onto
proliferating human cells (1,6-8).
AlloDerm (LifeCell, Woodlands, TX, USA) was
recommended by many investigators as a more
suitable dermal matrix for development of an oral
mucosal equivalent (1,9). AlloDerm is an acellular
nonimmunogenic cadaveric human dermis. It has a
polarity by which one side of the material has a basal
lamina to grow epithelial cells on, and the other side,
an underlying porous dermal matrix, allows ingrowth
of fibroblasts and angiogenic cells (1,10).
110

In 1999, Izumi et al (1) successfully developed an
ex vivo composite oral mucosal equivalent that
consisted of stratified epidermis on an acellular
nonimmunogenic cadaveric human dermis matrix,
and they have optimized their method (1,4,11-15).
Moreover, after in vivo studies, it was reported that ex
vivo produced oral mucosa equivalent (EVPOME)
appears to be an acceptable oral mucosal substitute
for human intraoral grafting procedures (7,13,14).
In the current study, an optimized version of the
original method described by Izumi et al in 1999 (1)
was used to obtain a much cleaner keratinocyte
culture by using an animal-product-free culture
medium (EpiLife Cascade Biologics, Portland, OR,
USA) supplemented with human keratinocyte growth
factors (EDGS Cascade Biologics, Portland, OR,
USA). EVPOME developed by this optimized method
can be more suitable for intraoral grafting procedures.
Materials and methods
University of Michigan Internal Review Board
approved protocol utilized human oral keratinized
tissue for the development of an oral mucosa
equivalent.
Dissociating human oral keratinocytes from
primary tissue
The basic “culture medium” [chemically defined
culture medium (EpiLife Cascade Biologics, Portland,
OR, USA) supplemented with human keratinocyte
growth factors (EDGS Cascade Biologics, Portland,
OR, USA), 125 μg/mL gentamycin, and 1 μg/mL
fungizone (Sigma Chemicals Co.)] was prepared with
a calcium concentration of 0.06 mM.
In the outpatient clinic, under local anesthesia, a 5
× 5 mm keratinized oral mucosa sample was obtained
from retromolar pad of a 19-year-old female patient
undergoing a dental extraction. The tissue sample was
transported in “washing solution” [phosphate++
++
buffered saline (PBS) (Ca and Mg free) which was
supplemented with 125 μg/mL gentamycin, and 1
μg/mL fungizone (Sigma Chemicals Co.)]. The oral
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mucosal sample was placed in a new washing
solution, scraped to remove blood, and trimmed of
excess tissue. The mucosal tissue in the 0.04% trypsin
solution (Sigma Chemicals Co.) was digested
overnight at room temperature to allow the separation
of the epithelium at the suprabasal layer. The next day,
after inactivation of the trypsin by 0.0125% trypsin
inhibitor (DTI Cascade Biologics, Portland, OR,
USA), the epithelial layer of the mucosal sample was
mechanically separated above the basal layer, and the
interface area was scraped to dissociate the basal cells
from the sub-mucosal layer. The cells in the filtered
(by 240 μm nylon mesh filter) cell suspension were
counted with a hematocytometer. After it was
centrifuged (5 min/1000 rpm/room temperature),
and re-suspended by 5 mL culture medium, 2.3 × 106
cells were plated in a T-25 flask (Laboratory Science
Co. Corning, NY, USA), and incubated at 37 °C in 5%
CO2. The medium was changed 2 days after initial
plating of the cells. The culture was fed every other
day with culture medium containing a low calcium
concentration of 0.06 mM. After 10 days, oral mucosa
keratinocytes were harvested when they reached 70%80% confluent. Some of the first passaged
keratinocytes were split and used for the fabrication of
EVPOME. Others were re-plated into the 3 different
T-25 flasks at a density of 2.0 × 104 cells/cm2 and used
for subsequent cell proliferation assays in monolayer
culture.
Preparation of AlloDerm
AlloDerm (LifeCell, Woodlands, TX), the acellular
human cadaver dermis, was cut into circular pieces
11.3 mm diameter in order to conform to the area of
a 48-well microplate (Corning Inc. Corning, NY,
USA). Two circular samples were rehydrated in
washing solution. Epidermal and dermal surfaces of
the samples were identified and transferred to the 48well microplate with epidermal surfaces up. They
were pre-soaked and kept overnight at 4 °C in 100 μL
of PBS and Human Type IV Collagen 5 μg/cm2 to
enhance attachment of seeded keratinocytes.
Production of keratinocytes on AlloDerm
Oral keratinocytes from the first passage of
actively dividing cells were used to seed onto
AlloDerm samples. They were harvested by adding a
solution of trypsin-ethylenediaminetetra-acetic acid

(Trypsin-EDTA, TE Cascade Biologics, Portland, OR,
USA) at 37 °C. Trypsin-EDTA activity was inhibited
with an equal volume of 0.0125% trypsin inhibitor.
Disaggregated cells were collected, counted,
centrifuged, and re-suspended. Cells were seeded
onto AlloDerm samples in 2 different 48-well
microplates at the density of 1.8 × 105 cells. At that
time, 1.2 mL of “culture medium” containing a high
concentration of calcium (1.2 mM) was gently added
to 48-well microplates without disturbing the cells.
The oral keratinocyte-AlloDerm composites were
cultured and submerged for 4 days in the 48-well
culture microplates. Composites were fed daily during
this period with culture medium.
After incubating the composites in a submerged
environment for 4 days, they were transferred to
organotypic tissue culture flasks (Organogenesis Inc.
Canton, MA, USA). The medium was changed every
other day for 7 more days. The organotypic tissue
culture flasks allowed the composites to grow at an
air-liquid interface. This culturing technique has been
shown to encourage stratification of the epithelial
layers (1,16).
Histological examination
EVPOMEs were removed from the culture at 11
days post-seeding of the keratinocytes and fixed in
10% formaldehyde (Figure 1). The fixed EVPOMEs
were embedded in paraffin and cut at 5 μm and
stained with hematoxylin and eosin.
Results
After the enzymatic dissociation of keratinized
oral mucosal tissue samples with 0.04% trypsin
overnight, keratinocyte proliferation was enhanced
and shown to be in a hyperproliferative state without
evidence of fibroblastic contamination when they
were cultured in a chemically defined serum-free
culture medium (Figure 2). Histologically, on day 11,
EVPOMEs development showed multilayered
epithelium comprising basal, suprabasal, and
parakeratinized layers (Figure 3). The epithelial
architecture of EVPOMEs resembled that of normal
mucosa (16) (Figure 4). Highly stratified EVPOMEs
showed evidence of parakeratosis. Keratinocytes of
the basal layer were cuboid or circular, and they were
aligned along the AlloDerm surface. Under the basal
111
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Figure 1. Macroscopic appearance of EVPOME sample before
histologic examination.

Figure 3. Histological appearance of EVPOME sample stained by
hematoxylin and eosin showed that multilayered
epithelial layer comprised a basal layer (black arrow),
suprabasal layer (yellow arrow), and a parakeratinized
layer (blue arrow). Under the basal layer of EVPOMEs.
AlloDerm shows no evidence of any cellular
components and consisted of interlacing dense collagen
bundles of varying sizes, indicating that the structural
integrity of the extracellular matrix was intact (red
arrows) (H.E. 160×).

Discussion
Tissue-engineered oral mucosal equivalents have
been developed for clinical applications and an in
vitro test model for wound healing, mucotoxicity, and
biocompatibility studies. In recent years, research has
concentrated
on
the
development
and
characterization of human oral mucosal equivalents
by introducing new dermal scaffolds and epithelial
cell culture methods (17).

Figure 2. Hyperproliferative state of keratinocytes in a chemically
defined serum-free culture medium (160×).

layer of EVPOMEs AlloDerm showed no evidence of
any cellular components and consisted of interlacing
dense collagen bundles of varying sizes, indicating
that the structural integrity of the extracellular matrix
was intact (Figure 2) (1,3).
112

The protocol developed by Izumi et al. (1) to
produce ex vivo oral mucosa equivalent for intraoral
grafting procedures has several advantages over
previously published techniques (1,3). Firstly, they
could propagate and expand oral keratinocytes in
vitro, in a defined culture medium devoid of the use
of an irradiated 3T3 mouse feeder layer. The
combination of human cells and 3T3 mouse
fibroblasts may contribute to transfection of the
mutational or xenogenic DNA to human
keratinocytes. That is why it is suggested that the
defined culture medium would be more acceptable for
human use. The second modification of the Izumi et
al.’s protocol is the use of trypsin to dissociate basal
cells from the dermal layer in association with the
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Figure 4. Histologically, the epithelial architecture of EVPOMEs (H.E. 160×) (a) resemble that of a normal oral mucosa (H.E. 200×) (b)
(15). Black arrows show cuboid or circular keratinocytes of basal layer in normal oral mucosa and EVPOME samples

primary cultivation in a defined culture medium. It
has allowed us to successfully culture, amplify, and
harvest a pure population of keratinocytes without
contamination of fibroblasts (1,8,18).
In 1975, Rheinwald and Green (5) introduced a
method to grow human keratinocytes in serial culture
in vitro and produce single-layer epithelial sheets.
Monolayer cultures have been extremely helpful in the
study of the basic biology, and responses to stimuli, of
both oral and skin keratinocytes, and many studies
have used them. However, the oral epithelium and
epidermis are complex multilayer structures, with
cells undergoing terminal differentiation, and
monolayer cultures may not be a good model of what
is happening in vivo. The culture of keratinocytes on
permeable cell culture membranes at the air/liquid
interface facilitated the construction of multilayer
sheets of epithelium, which resemble native
epithelium and show signs of differentiation, such as
basement membrane formation, different cytokeratin
expression, and keratinization if the origin of the
keratinocytes is keratinized mucosa (17). In this
preliminary study, histological samples of EVPOME
stained by hematoxylin and eosin showed
multilayered epithelium comprising basal, suprabasal,
and parakeratinized layers.

Another important element in oral mucosa and
skin reconstruction is the scaffold that supports the
cells. Choosing the right scaffold with ideal
biocompatibility, porosity, biostability, and
mechanical properties is a crucial step in tissue
engineering. In this preliminary study, acellular
cadaveric human dermis (AlloDerm) was used as a
scaffold for the tissue engineering of oral mucosa.
AlloDerm has a polarity by which one side has a basal
lamina suitable for epithelial cells, and the other side
has intact vessel channels suitable for fibroblast
infiltration. It is a durable acellular dermis that retains
extracellular matrix proteins and intact basement
membrane structure, while being surgically
manageable (1,17). Although several investigations
had been reported on the use of either AlloDerm or
deepidermized human dermis in the development of
reconstituted skin and oral mucosa (13,19,20), the
first ex vivo produced oral mucosa equivalent utilizing
AlloDerm in a serum-free defined culture medium
without an irradiated xenogenic feeder layer was
reported by Izumi et al. in 1999 (1). In their in vivo
animal studies, the AlloDerm portion of the
EVPOME showed no evidence of an adverse
inflammatory reaction or rapid remodeling reaction
in the early stages after grafting but rather appeared to
113
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act as a biomimetic template that promoted the
intradermal migration and infiltration of fibroblasts
and host cells. Furthermore, AlloDerm with
epithelium of EVPOME showed marked remodeling
of the collagenous bundles in comparison with
AlloDerm without epithelium. This eventually
progressed to a point of contracture of the EVPOME
21-day postgrafting (13).
When clinical transplantation of EVPOME was
compared with that of AlloDerm alone or of artificial
dermis, it resulted in: 1) earlier initiation of
epithelization, 2) a shorter period until complete
healing, and 3) negligible scar contracture (14). Hotta
et al. (14) suggested that the EVPOME graft may be a
more acceptable oral mucosa substitute for human
intraoral grafting procedures, resulting in a more
favorable wound healing response. The advantage of
the EVPOME over the AlloDerm may have been
related to the persistence of a transplanted epithelial
basal cell layer resulting in the development of a more
rapid and mature epithelium. In the recent literature,
it has been stated that the persistent basal layer of
grafted keratinocytes and/or the initial presence of an
intact epithelial layer of EVPOME may release
cytokines and growth factors that are known to be
secreted by keratinocytes (12). Furthermore, it has

been shown by in vivo studies that the vascular
endothelial growth factor (VEGF) is secreted by
EVPOME grafts and it may contribute to early
vascularization after grafting (3,12,13).
It was reported that the absence of adequate
keratinized mucosa around implants supporting
overdentures was associated with higher plaque
accumulation, gingival inflammation, bleeding on
probing, and mucosal recession (21). From a 4 × 4
mm2 punch biopsy of the palate, it would take
approximately 40 days to fabricate an EVPOME the
2
size of approximately 65 × 150 mm . This size of
EVPOME should be large enough to cover most
mucosal defects (2). This method may be used during
implant treatment. The procedure may be initialized
at the implant insertion phase, and subsequently the
gathered graft might be used during the second
surgery for submerged implants.
Recent and future studies entail shortening the
time for fabrication of the EVPOMEs necessary for
reconstructive surgery, as well as isolating a long-live
transplanted cell that would be able to continue
secretion of a transfected recombinant product, such
as a cytokine or growth factor, over a sustained period
of time. This will require the identification and
isolation of a putative progenitor/stem cell (4,15).
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